Taking aim at mysterious DNA structures in the battle against cancer

Nov 04, 2009

Designers of anti-cancer drugs are aiming their arrows at mysterious chunks of the genetic material DNA that may play a key role in preventing the growth and spread of cancer cells, according to an article in the current issue of Chemical & Engineering News, ACS' weekly newsmagazine.

C&EN Deputy Assistant Managing Editor Stu Borman notes that the structures, which scientists term "quadruplexes" because they have four-sided structures, are a genre of folded DNA that may help control whether genes are switched on or off. Quadruplexes sometimes form near genes that foster the growth of cancer cells. Some scientists thus regard them as promising targets for developing new anti-cancer drugs.

Drugs that interact with quadruplexes could help kill without harming healthy cells. In addition, they may side-step the serious problem of drug resistance, in which some drugs gradually lose their effectiveness against cancer. The article describes research on quadruplex-targeted drugs and explores the mysteries about how quadruplexes form, disappear, and work.

More information: "Promoter Quadruplexes", This story is available at pubs.acs.org/cen/science/87/8744sci1.html

Source: American Chemical Society (news : web)

Explore further: ACG: Recent increase in incidence of young-onset CRC

add to favorites email to friend print save as pdf

Related Stories

Freeing protein-based drugs from bacteria's natural traps

Oct 13, 2008

In a finding that could speed the development of new protein-based drugs for fighting diabetes, hepatitis, and other diseases, researchers are reporting progress toward preventing or destroying an unusual structure that reduces ...

Tiny delivery system with a big impact on cancer cells

Dec 15, 2008

Researchers in Pennsylvania are reporting for the first time that nanoparticles 1/5,000 the diameter of a human hair encapsulating an experimental anticancer agent, kill human melanoma and drug-resistant breast ...

Recommended for you

Blood biomarker may detect lung cancer

7 hours ago

A new study shows that patients with stage I to stage III non-small cell lung cancer have different metabolite profiles in their blood than those of patients who are at risk but do not have lung cancer. The study abstract ...

ACG: Recent increase in incidence of young-onset CRC

23 hours ago

(HealthDay)—The incidence of young-onset colorectal cancer (CRC) is increasing, and the disease is more aggressive pathologically. These findings are being presented at the annual meeting of the American ...

User comments : 0